• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Camurus - Articles and news items

opioid-injection

Braeburn Pharmaceuticals and Camurus present positive data from opioid use disorder clinical studies

Industry news / 27 October 2016 / Niamh Louise Marriott, Digital Content Producer

Phase 3 study was designed to demonstrate the safety and efficacy of CAM2038 as compared to the sublingual buprenorphine in treating opioid use disorder…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +